DiaMedica's DM199 shows promise for Acute Ischemic Stroke, but caution is advised due to low market cap and trial outcome uncertainties. See more on DMAC here.
An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.
Prior to the Monday afternoon commemoration event, a group of WJC steering committee members, leading Jewish communal ...
The herbicide maker has settled or been ordered to pay out billions tied to lawsuits claiming the weedkiller Roundup causes ...